Clinical Trial Update: Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 randomized, double-blind, placebo-controlled study evaluated the safety and tolerability of an Enterovirus D68–specific monoclonal antibody in heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Infection

Drugs mentioned

• Enterovirus D68-specific monoclonal antibody

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Enterovirus Infection | Phase 1 | Status: COMPLETED